...
首页> 外文期刊>Disease markers >Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer
【24h】

Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer

机译:基于蛋白质组学的肺癌细胞因子研究方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Proteomic techniques are currently used to understand the biology of different human diseases, including studies of the cell signaling pathways implicated in cancer progression, which is important in knowing the roles of different proteins in tumor development. Due to its poor prognosis, proteomic approaches are focused on the identification of new biomarkers for the early diagnosis, prognosis, and targeted treatment of lung cancer. Cytokines are proteins involved in inflammatory processes and have been proposed as lung cancer biomarkers and therapeutic targets because it has been reported that some cytokines play important roles in tumor development, invasion, and metastasis. In this review, we aim to summarize the different proteomic techniques used to discover new lung cancer biomarkers and therapeutic targets. Several cytokines have been identified as important players in lung cancer using these techniques. We underline the most important cytokines that are useful as biomarkers and therapeutic targets. We also summarize some of the therapeutic strategies targeted for these cytokines in lung cancer.
机译:蛋白质组学技术目前用于了解不同人类疾病的生物学,包括对癌症进展有关的细胞信号传导途径的研究,这对于了解不同蛋白在肿瘤发育中的作用是重要的。由于其预后差,蛋白质组学方法集中在鉴定新的生物标志物,用于早期诊断,预后和肺癌的靶向治疗。细胞因子是参与炎症过程的蛋白质,并且已被提出为肺癌生物标志物和治疗靶标,因为据报道,一些细胞因子在肿瘤发育,侵袭和转移中起重要作用。在本文中,我们的目标是总结用于发现新的肺癌生物标志物和治疗靶标的不同蛋白质组学技术。使用这些技术已经确定了几种细胞因子被鉴定为肺癌中的重要参与者。我们强调最重要的细胞因子,可用作生物标志物和治疗目标。我们还总结了肺癌中这些细胞因子靶向的一些治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号